These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1412786)

  • 1. Identification and characterisation of two glycoproteins of molecular weights 60 and 180 kd from human multigravid placenta having strong in vitro immunosuppressive activity.
    Naiem M; Amiry N; Akhter S; Daar AS
    Transplant Proc; 1992 Oct; 24(5):1657-8. PubMed ID: 1412786
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of murine placental glycoproteins in relation to in vivo and in vitro immunomodulatory properties against H-2 antigens.
    Gupta GS; Kinsky RG
    Nephrologie; 1988; 9(4):167-75. PubMed ID: 2975359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity in buffalo placenta.
    Mehta S; Rajput YS
    Indian J Exp Biol; 1999 Oct; 37(10):959-64. PubMed ID: 10783753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of in vitro lymphocyte reactivity to PHA by lysates from human placentae: lack of correlation with gravida number.
    Naiem M; Amiry N; Hag A; Akhter S; Daar AS
    Transplant Proc; 1992 Oct; 24(5):1654-5. PubMed ID: 1412784
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunomodulatory effects of human placenta gangliosides.
    Dyatlovitskaya EV; Kryukova EV; Suskova VS; Emez VI; Bergelson LD
    Biomed Sci; 1990 Apr; 1(4):397-400. PubMed ID: 2151928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular immunosuppressive peptide.
    Pöllänen P; Söder O; Uksila J; Nikula H; Kaipia A; Kangasniemi M; Punnonen J; Huhtaniemi I; Parvinen M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1144-6. PubMed ID: 2539667
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin E2-mediated suppression of human maternal lymphocyte alloreactivity by first-trimester fetal macrophages.
    Yagel S; Palti Z; Gallily R
    Obstet Gynecol; 1988 Oct; 72(4):648-54. PubMed ID: 2971148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonspecific suppression of in vitro immune responses by placental and nonplacental tissues.
    Drake BL; Rodger JC
    Transplant Proc; 1985 Apr; 17(2):1653-4. PubMed ID: 3157248
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA Class I protein expression in the human placenta.
    Blaschitz A; Hutter H; Dohr G
    Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoactive products of human placenta (III): Characterization of an inhibitor affecting lymphocyte proliferation.
    Menu E; Jankovic DL; Theze J; David V; Chaouat G
    Reg Immunol; 1990-1991; 3(5):254-9. PubMed ID: 2129609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune tolerance of mother against fetus and placenta].
    Donat H
    Allerg Immunol (Leipz); 1986; 32(2):79-86. PubMed ID: 2425616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells.
    Jones BJ; Brooke G; Atkinson K; McTaggart SJ
    Placenta; 2007; 28(11-12):1174-81. PubMed ID: 17714779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDO: a crossroads of immunology and physiology?
    Entrican G
    J Reprod Immunol; 2004 Apr; 61(2):63-5. PubMed ID: 15063629
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responsiveness against the human placenta. II. Response with xenogeneic lymphocytes in culture.
    Davies M; McLaughlin ME; Sutcliffe RG
    Immunology; 1982 Nov; 47(3):469-76. PubMed ID: 6215338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of pregnancy-associated glycoproteins from placenta of the American bison (Bison bison) at first half of pregnancy.
    Kiewisz J; Sousa NM; Beckers JF; Vervaecke H; Panasiewicz G; Szafranska B
    Gen Comp Endocrinol; 2008 Jan; 155(1):164-75. PubMed ID: 17543308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of intrauterine immune suppression during pregnancy in a species with epitheliochorial placentation.
    Croy BA; Wood W; King GJ
    J Immunol; 1987 Aug; 139(4):1088-95. PubMed ID: 2956324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological studies of the human placenta. Characterization of immunoglobulins on trophoblastic basement membranes.
    Faulk WP; Jeannet M; Creighton WD; Carbonara A
    J Clin Invest; 1974 Nov; 54(5):1011-9. PubMed ID: 4278853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level.
    Frängsmyr L; Baranov V; Nagaeva O; Stendahl U; Kjellberg L; Mincheva-Nilsson L
    Mol Hum Reprod; 2005 Jan; 11(1):35-41. PubMed ID: 15579659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a factor blocking a cellular cytotoxicity reaction in pregnant serum.
    Fizet D; Bousquet J; Piquet Y; Cabantous F
    Clin Exp Immunol; 1983 Jun; 52(3):648-54. PubMed ID: 6872319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro study of comparative immunosuppressive activity of sera from pregnant women on an in vitro cellular cytotoxic reaction].
    Fizet D; Bousquet J; Chateaureynaud-Duprat P; Moulinier J
    C R Seances Acad Sci III; 1981 Nov; 293(10):583-8. PubMed ID: 6800575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.